Free Newsletter
Docs more receptive to reps at industry confabs
Here's a tip for sales reps barred from certain physicians' offices--catch them at a meeting instead. As the number of doctors who readily accept calls from pharma reps continues to shrink, sales folks are looking for work-arounds. And one that seems to work is chatting with docs at industry meetings, a new survey shows.
Even "no-see" docs would chat with reps at live events, a survey by educational-meeting provider Pri-Med reveals. Some 71 percent of them, in fact, actually have done so, the survey says. "It's about the right location and the right time," Sam Bishop, Pri-Med director of research, tells Medical Marketing & Media.
Now, Pri-Med has a vested interest in making educational meetings sound attractive; those meetings are its business. But the observations make sense--like many people, doctors are probably more receptive outside the office, where they aren't pressed by schedules and surrounded by staff. And they probably apply to other sorts of meetings besides the theater presentations and product forums that Pri-Med sponsors (and studied). So, maybe drugmakers should look at cutting their doc-office detailing budget and spending more on travel to physician meetings instead.
- check out the MM&M story
Related Articles:
Novartis sales calls to healthcare providers on the rise
The tough life of a pharma sales rep
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: